Literature DB >> 12066787

Immunocytochemistry reveals RANKL expression of myeloma cells.

Orhan Sezer, Ulrike Heider, Christian Jakob, Ivana Zavrski, Jan Eucker, Kurt Possinger, Christine Sers, Veit Krenn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12066787     DOI： 10.1182/blood-2002-01-0148

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  20 in total

1.  MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts.

Authors:  Sonia Vallet; Noopur Raje; Kenji Ishitsuka; Teru Hideshima; Klaus Podar; Shweta Chhetri; Samantha Pozzi; Iris Breitkreutz; Tanyel Kiziltepe; Hiroshi Yasui; Enrique M Ocio; Norihiko Shiraishi; Janice Jin; Yutaka Okawa; Hiroshi Ikeda; Siddhartha Mukherjee; Nileshwari Vaghela; Diana Cirstea; Marco Ladetto; Mario Boccadoro; Kenneth C Anderson
Journal:  Blood       Date:  2007-08-22       Impact factor: 22.113

Review 2.  unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance?

Authors:  Matthew T Drake
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

3.  The immune microenvironment of myeloma.

Authors:  Kimberly Noonan; Ivan Borrello
Journal:  Cancer Microenviron       Date:  2011-08-25

Review 4.  Multiple Myeloma and Bone: The Fatal Interaction.

Authors:  Silvia Marino; G David Roodman
Journal:  Cold Spring Harb Perspect Med       Date:  2018-08-01       Impact factor: 6.915

5.  Mechanisms of multiple myeloma bone disease.

Authors:  Deborah L Galson; Rebecca Silbermann; G David Roodman
Journal:  Bonekey Rep       Date:  2012-08-01

Review 6.  How B cells influence bone biology in health and disease.

Authors:  Mark C Horowitz; Jackie A Fretz; Joseph A Lorenzo
Journal:  Bone       Date:  2010-06-18       Impact factor: 4.398

7.  Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells.

Authors:  Tomoko Okada; Shingo Akikusa; Hiroaki Okuno; Masato Kodaka
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Expression of receptor activator of NF-kappaB ligand (RANKL) mRNA in human multiple myeloma cells.

Authors:  Ulrike Heider; Ivana Zavrski; Christian Jakob; Katharina Bängeroth; Claudia Fleissner; Corinna Langelotz; Kurt Possinger; Lorenz C Hofbauer; Volker Viereck; Orhan Sezer
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

Review 9.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

10.  Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.

Authors:  Ya-Wei Qiang; Bo Hu; Yu Chen; Ying Zhong; Bingyin Shi; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.